Candela's New GentleLASE Family of Lasers is Cleared for Wrinkles and Hair Removal.

Business Editors/Health/Medical Writers

WAYLAND, Mass.--(BUSINESS WIRE)--March 17, 2003

Candela Corporation (NASDAQ: CLZR) announced today that a new family of devices to be launched at next week's American Academy of Dermatology (AAD) Annual Meeting has received 510(k) clearance from the U.S. Food and Drug Administration for the treatment of wrinkles and large leg veins, and for unwanted hair removal. The Company also noted that the new family of devices, named the "MGL" family is 50% faster, 50% smaller, and significantly less expensive than competitive devices.

Gerard E. Puorro, Candela's President and CEO said: "The MGL family is what our market told us they wanted: multi-application devices that have faster treatment times, smaller footprints, and are more economical."

About Candela: Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 60 countries from offices in the United States, Europe, Japan and other Asian locations. Candela established the aesthetic laser market 14 years ago, and currently has an installed base of over 6,000 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer, M/F/H/V. Visit Candela on the Web at http://www.candelalaser.com.

Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. Candela's actual results could differ materially from those anticipated in Candela's forward-looking statements based on various factors, including without limitation: the cancellation or deferral of customer orders, dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, or changes in economic conditions. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC, including but not limited to, Candela's Annual Report on Form 10-K for the year ended June 29, 2002, and subsequent Quarterly Reports on Form 10-Q. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstances on which any such statement is based.